Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AMRX | US
-0.01
-0.12%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
30/08/2024
8.66
8.71
8.72
8.55
Amneal Pharmaceuticals Inc. together with its subsidiaries develops manufactures markets and distributes generics injectables biosimilars and specialty branded pharmaceutical products worldwide. The company operates through three segments: Generics Specialty and AvKARE. The Generics segment offers immediate and extended release oral solid powder liquid sterile injectable nasal spray inhalation and respiratory biosimilar ophthalmic film transdermal patch and topical products. The Specialty segment develops promotes sells and distributes pharmaceutical products with focus on central nervous system disorders including Parkinson's disease and endocrine disorders. This segment also provides Rytary an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease post-encephalitic parkinsonism and parkinsonism; Unithroid for the treatment of hypothyroidism; and IPX203 a pipeline product for Parkinson's disease. The AvKARE segment offers pharmaceuticals medical and surgical products and services primarily to governmental agencies the Department of Defense and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers distributors hospitals chain pharmacies and individual pharmacies. The company was formerly known as Atlas Holdings Inc. and changed its name to Amneal Pharmaceuticals Inc. in 2018. Amneal Pharmaceuticals Inc. was founded in 2002 and is headquartered in Bridgewater New Jersey.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
14.5%1 month
59.3%3 months
39.5%6 months
43.8%-
6.30
86.10
-44.31
0.73
15.25
2.06
-
576.39M
2.64B
2.64B
-
13.74
-75.00
17.10
-148.99
3.12
1.65
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.89
Range1M
2.22
Range3M
2.43
Rel. volume
0.65
Price X volume
8.35M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Catalyst Pharmaceuticals Inc | CPRX | Drug Manufacturers-Specialty & Generic | 20.25 | 2.40B | 1.35% | 36.16 | 0.55% |
Amphastar Pharmaceuticals Inc | AMPH | Drug Manufacturers-Specialty & Generic | 48.74 | 2.39B | -0.25% | 15.47 | 87.00% |
Bausch Health Companies Inc | BHC | Drug Manufacturers-Specialty & Generic | 5.93 | 2.18B | 1.02% | n/a | 0.00% |
PAR Technology Corporation | PAR | Drug Manufacturers-Specialty & Generic | 53.99 | 1.96B | 0.11% | n/a | 65.19% |
Supernus Pharmaceuticals Inc | SUPN | Drug Manufacturers-Specialty & Generic | 35.16 | 1.94B | 0.46% | 390.67 | 4.18% |
Tilray Inc | TLRY | Drug Manufacturers-Specialty & Generic | 1.71 | 1.44B | 0.59% | n/a | 0.00% |
Harrow Health Inc | HROW | Drug Manufacturers-Specialty & Generic | 40.46 | 1.44B | 3.06% | n/a | 331.16% |
Collegium Pharmaceutical Inc | COLL | Drug Manufacturers-Specialty & Generic | 38.46 | 1.24B | -0.39% | 14.46 | 258.31% |
OPKO Health Inc | OPK | Drug Manufacturers-Specialty & Generic | 1.68 | 1.17B | 5.66% | n/a | 19.31% |
Evolus Inc | EOLS | Drug Manufacturers-Specialty & Generic | 15.89 | 1.00B | 0.38% | n/a | 656.27% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
VeriFone Systems Inc | PAY | Building Products & Equipment | 22.73 | 2.83B | 2.11% | 87.42 | 2.10% |
HNI Corporation | HNI | Building Products & Equipment | 53.85 | 2.54B | 1.32% | 21.80 | 76.47% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 59.66 | 1.73B | 0.15% | 22.26 | 56.33% |
Fox Factory Holding Corp | FOXF | Recreational Vehicles | 40.48 | 1.69B | -0.47% | 41.31 | 64.69% |
REV Group Inc | REVG | Recreational Vehicles | 31.84 | 1.65B | 1.69% | 7.49 | 66.74% |
Steelcase Inc | SCS | Building Products & Equipment | 14.14 | 1.61B | 1.87% | 18.36 | 69.98% |
Janus International Group Inc. | JBI | Building Products & Equipment | 10.99 | 1.60B | 0.92% | 12.35 | 116.21% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 7.07 | 1.27B | 0.43% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.74 | 1.17B | -2.65% | n/a | 0.00% |
Interface Inc | TILE | Textile Manufacturing | 18.88 | 1.10B | 0.16% | 16.71 | 106.26% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 15.25 | - | Par |
Ent. to Revenue | 2.06 | - | Cheaper |
PE Ratio | - | 28.45 | - |
Price to Book | 86.10 | 11.25 | Expensive |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 39.54 | - | Lower Risk |
Debt to Equity | -44.31 | -0.58 | Cheaper |
Debt to Assets | 0.73 | 0.43 | Expensive |
Market Cap | 2.64B | - | Emerging |